United Kingdom🏛️ PoliticsProgressiveOverlooked by conservatives
UK Government to Extend Palantir’s NHS Contract by Two Years
The UK government intends to extend Palantir’s £330 million contract with the National Health Service by two years, rejecting calls from Labour MPs, medical unions, and activists to terminate the agreement early. Although ministers held a break clause option in February, a review determined that replacing the provider within four months would cause significant disruption, leading to plans for a potential British alternative in two years. Campaign group Foxglove criticized this assessment as factually incorrect, noting that the contract already mandates up to 24 months of bridging support to ensure service continuity during any transition. Opposition to the extension is fueled by concerns over Palantir’s collaborations with the US and Israeli governments, as well as reports that many UK hospitals are not actively utilizing the platform provided by the firm. Additionally, recent disclosures indicate that critical MPs have received intimidating correspondence from Palantir, prompting human rights organizations like Amnesty International to demand immediate termination of the partnership.
The United Kingdom government intends to extend the controversial £330 million contract between the National Health Service and American technology firm Palantir by two years. This decision follows a recent review which determined that terminating the agreement immediately through a contractual break clause would cause excessive disruption to hospital operations. Instead of severing ties now, ministers are preparing to launch a procurement process for a domestic technological alternative, aiming to replace Palantir within twenty-four months. The move has drawn sharp criticism from Labour members of parliament, medical unions, and activist groups who argue that the company lacks legitimacy due to its international partnerships and political associations. The contract allows the government to trigger a break clause in February. However, internal assessments indicated that swapping providers within a four-month window was impractical. Consequently, officials are drafting plans to transition to a British-based solution over a longer period. A representative from the tech justice campaign group Foxglove dismissed the rationale for the extension. Tom Hegarty, the group's head of communications, stated that the claim regarding practicality was nonsense. He noted that the existing contract specifically obligates Palantir to provide bridging support for up to twenty-four months if the deal is terminated, thereby ensuring service continuity during any transition. Opposition to Palantir’s presence in British public services has intensified recently. The firm faces scrutiny over its collaborations with the administration of President Donald Trump and the Israeli military. Its co-founder, Peter Thiel, has previously made critical statements regarding the National Health Service. Last week, investigative reporting revealed that dozens of UK hospitals purportedly benefiting from a Palantir-built platform were not actually utilizing the system. Additionally, it emerged that British lawmakers who criticized the company in Parliament received intimidating correspondence from Palantir representatives. Amnesty International’s UK crisis campaigner, Tom Guha, urged ministers to end the relationship immediately. He argued that patients and healthcare workers had pushed for an exit strategy. Guha highlighted that Palantir has publicly acknowledged supporting Israel’s military in war-related missions. He asserted that any company linked to genocide has no place in the National Health Service. The plan to extend the contract is expected to receive final approval soon. Green Party leader Zack Polanski condemned the decision as a betrayal by the Labour government. He accused the party of allowing corporate capture of the health service by a corporation that supports genocide and Donald Trump. Polanski suggested that payments to former Labour figures, including Peter Mandelson and Tom Watson, may have influenced the outcome. He pointed out that evidence of patient benefit is heavily disputed by NHS staff, and many NHS trusts have rejected the use of Palantir’s platform. Louis Mosley, Palantir’s chief executive for the UK and Europe, defended the company’s position. He described the potential termination of the contract as putting politics above patients. Mosley accused critics of suffering from Palantir Derangement Syndrome. The company holds contracts supplying artificial intelligence capabilities to the Israeli military and to Donald Trump’s homeland security initiatives. Founder Peter Thiel has questioned democratic norms, stating that tech companies can unilaterally change the world and calling technology an incredible alternative to politics. Recent investigations have cast doubt on the effectiveness of the technology. Medical charity Medact disclosed that twenty-nine NHS trusts, which were listed as realizing benefits from the AI-powered federated data platform, had either declared the system was not live or confirmed they were not using any of its applications. These findings, derived from freedom of information requests, bolster arguments for cancelling the deal. Fears persist that patient data could be misused by Palantir, given its close work with Israel’s military during the conflict in Gaza and its sales of services to US Immigration and Customs Enforcement. Chi Onwurah, a Labour member of parliament and chair of the parliamentary science and technology committee, advised the government to exercise the 2027 break clause. She questioned whether the hype surrounding Palantir’s products matched reality, especially if many trusts do not perceive value in the system. An analysis by the Health Foundation published in July found that a patient discharge tool developed by Palantir made no meaningful difference in reducing discharge delays, contradicting claims made by NHS England. In response to public pressure, Palantir has increased its lobbying efforts. In September, the firm appointed former Labour deputy leader Tom Watson as a senior vice president. Watson subsequently stated that mob rule should not dictate how public contracts are awarded. Former Labour leader Jeremy Corbyn was among those who received a letter from Mosley, whose grandfather was the deceased fascist leader Oswald Mosley. Corbyn stated that Palantir’s tactics of intimidation would fail and would not silence him. A company spokesperson maintained that the software helps deliver better care, citing more operations and lower discharge delays.
Go to the primary sources (1)
The official sources this coverage is built on. Read them directly to bypass framing.
An investigation by the medical charity Medact found that 29 NHS Trusts claimed to benefit from Palantir’s AI-powered federated data platform, yet many reported the system was not live or unused. These findings, derived from freedom of information requests, support calls for the UK government to cancel the £330 million contract due to concerns over patient data security and Palantir’s ties to controversial entities like ICE and the Israeli military. Labour MP Chi Onwurah urged the government to invoke a 2027 break clause, citing a Health Foundation study that found Palantir’s discharge tools offered no meaningful improvement. Meanwhile, Palantir intensified its lobbying efforts, appointing former Labour deputy leader Tom Watson as a senior vice president, while sending intimidating letters to critical MPs, including Jeremy Corbyn. A Palantir spokesperson defended the software, claiming it improves care delivery through increased operations and reduced discharge delays.
Bias read (Progressive): The article frames the issue around 'spytech' and 'genocide', highlights 'intimidating' corporate tactics, and relies heavily on critical Labour politicians and charities rather than balanced industry defense.
Why factuality (90): Highly detailed and accurate regarding the FOI findings (29 trusts) and the Health Foundation analysis. Correctly identifies the specific break clause year (2027) and the appointment of Tom Watson. All major claims align with the cross-source consensus and specific reporting details.
Why objectivity (55): Strongly biased in tone. Uses emotionally charged descriptors like 'genocide in Gaza' and 'spytech firm'. Frames the issue entirely through the lens of opposition to Palantir, omitting any direct defense from the company or the government beyond the context of the controversy.
The Guardian (UK)IndependentProgressiveFactual: no official source document/info detectedObjective 65
The UK government intends to extend the controversial £330 million contract with US tech firm Palantir for its National Health Service (NHS) artificial intelligence system, according to reports from the Financial Times. While Health Secretary Yvette Cooper faces pressure from MPs and campaigners to terminate the deal, a recent review determined that invoking a break clause would cause excessive disruption to hospital operations. Ministers plan to initiate a procurement process for a domestic alternative within the next two years. Palantir executives criticized potential termination as prioritizing politics over patient care, while Green Party leader Zack Polanski condemned the extension as a betrayal involving corporate capture. The article notes that Palantir maintains contracts with the Israeli military and US homeland security agencies, and highlights ongoing disputes among NHS staff regarding the platform's benefits.
Bias read (Progressive): The article frames the decision through critical quotes from opposition figures, emphasizes Palantir's ties to controversial geopolitical actors, and uses loaded terms like 'controversial' and 'corporate capture'.
Why factuality: no official source document/info detected
Why objectivity (65): More balanced than the previous two entries. It explicitly includes the counter-argument from Palantir's CEO ('Palantir Derangement Syndrome') alongside the harsh criticism from the Green Party. While still framed around the 'controversy', it allows multiple viewpoints to stand without excessive edi
Novara MediaIndependentProgressiveFactual: no official source document/info detectedObjective 60
The UK government intends to extend Palantir’s £330 million contract with the National Health Service by two years, rejecting calls from Labour MPs, medical unions, and activists to terminate the agreement early. Although ministers held a break clause option in February, a review determined that replacing the provider within four months would cause significant disruption, leading to plans for a potential British alternative in two years. Campaign group Foxglove criticized this assessment as factually incorrect, noting that the contract already mandates up to 24 months of bridging support to ensure service continuity during any transition. Opposition to the extension is fueled by concerns over Palantir’s collaborations with the US and Israeli governments, as well as reports that many UK hospitals are not actively utilizing the platform provided by the firm. Additionally, recent disclosures indicate that critical MPs have received intimidating correspondence from Palantir, prompting human rights organizations like Amnesty International to demand immediate termination of the partnership.
Bias read (Progressive): Framing relies exclusively on critical activist and union voices, uses loaded terms like 'spytech' and 'genocide', and omits any defense from the government or Palantir.
Why factuality: no official source document/info detected
Why objectivity (60): Uses loaded terminology such as 'spytech firm' and quotes critics who describe the government's reasoning as 'nonsense'. While it presents the opposing view via quotes, the overall framing leans heavily toward the critical perspective, lacking balance.
How each side covered it
The same event, grouped by the political lean of the outlets covering it.
progressive
center
conservative
★
How each side covered it
Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.